Use of glycopyrrolate in the treatment of meniere's disease

  title={Use of glycopyrrolate in the treatment of meniere's disease},
  author={Ian S. Storper and Jaclyn B. Spitzer and M Scanlan},
  journal={The Laryngoscope},
Objectives/Hypothesis: The objective of this study was to determine whether glycopyrrolate is useful as a vestibular suppressant in patients with Meniere's disease. The tested hypotheses were that glycopyrrolate would decrease the perception of dizziness measured by the Dizziness Handicap Inventory in patients with Meniere's disease and that placebo would cause no such decrease. Study Design: Randomized, prospective. Methods: Thirty‐seven subjects with a diagnosis of Meniere's disease were… 
Depression in Ménière's disease: a systematic review and meta-analysis.
The prevalence of depression in patients with Ménière's disease is nearly 50 per cent, and treating otolaryngologists should have a low threshold to screen and refer appropriately.
Medical therapy in Ménière's disease
The medical management of MD is still empiric and based on lifestyle changes and pharmacotherapy that remain the primary therapy in definite MD, while ablative and transtympanic therapies represent the treatment of second choice.
Menière's disease.
Pharmacological Treatment of Vertigo
This review discusses the physiology and pharmacological treatment of vertigo and related disorders. Classes of medications useful in the treatment of vertigo include anticholinergics,
Clinical Practice Guideline: Ménière’s Disease
  • G. Basura, M. Adams, E. Buchanan
  • Medicine
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2020
This clinical practice guideline is to improve the quality of the diagnostic workup and treatment outcomes of Ménière’s disease while reducing unindicated diagnostic testing and/or imaging.
A Review of Medical Treatment for Ménière's Disease
  • J. Claes
  • Medicine
    Acta oto-laryngologica. Supplementum
  • 2000
A review of the literature on drug therapy for Ménière's disease using Medline to search for publications between January 1978 and September 1998 found only betahistine and diuretics appear to have proven efficacy in double-blind studies on the long-term control of vertigo.
Nocebo Effect in Menière's Disease: A Meta-analysis of Placebo-controlled Randomized Controlled Trials.
  • P. Dimitriadis, P. Zis
  • Medicine
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • 2017
Nocebo is an important confounding factor of the reported AEs in RCTs for treatment of Menière disease and subsequently in the clinical practice and Reporting of R CTs in MD is suboptimal and authors are recommended to endorse the CONSORT checklist.
Meniere's disease in Finland. An epidemiological and clinical study on occurrence, clinical picture and policy.
The symptom complex originating from the inner ear, known as Meniere's disease, was studied especially from the epidemiologic point of view and the validity of the diagnostic assessment was examined using the latest guidelines of the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology Head and Neck Surgery as a gold standard.
Meniere’s disease in Finland. An epidemiological and clinical study on occurrence, clinical picture and policy
The prevalence and incidence of definite cases of Meniere’s disease appeared to be lower in Finland than could be expected based on previous international studies, and an evident need for up-to-date therapy recommendations for Meniere's disease in Finland.
Drug–Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications
This review searched articles published until 30 August 2021, and described both pharmacokinetic and pharmacodynamic DDIs in patients with vestibular disorders, focusing the interest on their clinical implications and on risk management strategies.


Development of the Tinnitus Handicap Inventory.
The Tinnitus Handicap Inventory is a self-report measure that can be used in a busy clinical practice to quantify the impact of tinnitus on daily living and yielded excellent internal consistency reliability.
The development of the Dizziness Handicap Inventory.
The final version of the DHI was administered to 106 consecutive patients and demonstrated good internal consistency reliability, with the exception of the physical subscale, the mean values for DHI scale scores increased significantly with increases in the frequency of dizziness episodes.
Medical Management of Meniere's Disease
A critical overview of the scientific and clinical basis for these various pharmacological agents used in the management of Meniere's disease is discussed.
Glycopyrrolate methobromide
The results of this study support the hypothesis that the magnitude of the antisialic effect of glycopyrrolate is dose-related, and the drying effect of glucose is very much more intense than that of atropine.
Clinical neurophysiology of the vestibular system.
This book provides a framework for understanding the pathophysiology of diseases involving the vestibular system and outlines the important features in the patient's history, examination, and laboratory evaluation that determine the probable site of lesion.
Cognitive and somatic item response pattern of pain patients, psychiatric patients, and hospital employees.
Although psychiatric inpatients endorsed equivalent levels of somatic and cognitive items, the pain patients' reports of psychological distress were limited primarily to somatic signs of anxiety and depression, and the interpretation of pain patients's psychological profiles and subsequent treatment recommendations may be inappropriate if based on normative data obtained from psychiatric and/or normal populations.
Assessment of depression: the depression inventory.